C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/1999
11/23/1999	US5990128 Administering an antagonist that binds to a human alpha-1c adrenergic receptor with a binding affinity at least 691-fold higher than the binding affinity with which the antagonist binds to a human alpha-1b adrenergic receptor
11/23/1999	US5990124 Neuromuscular relaxants
11/18/1999	WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999	WO1999058501A1 Compounds with growth hormone releasing properties
11/18/1999	WO1999049856A3 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
11/18/1999	CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/17/1999	EP0957093A2 Retrovial protease inhibitors
11/17/1999	EP0956286A1 Synthesis of terfenadine and derivatives
11/17/1999	CN1235605A Preparation of naphthyridine compounds and intermediate products
11/17/1999	CN1235603A N-substituted azaheterocyclic compounds
11/17/1999	CN1235596A Cyclic amine derivatives
11/17/1999	CN1235159A Preparation of sterically hindered amine ethers
11/16/1999	US5986131 RXR selective ligands
11/16/1999	US5986101 Reaction product of hindered amine with epoxy group for stabilizers for heat and light
11/16/1999	US5985899 Selective thrombin inhibitors
11/16/1999	US5985895 2-naphthamide derivatives and their therapeutic applications
11/16/1999	US5985881 Treatment and prevention of respiratory disorders, inflammatory eye diseases, inflammatory skin diseases, intestinal disorders, other inflammatory diseases
11/16/1999	US5985873 Useful in the diagnosis and treatment of feeding disorders such as obesity and bulimia and cardiovascular diseases such as essential hypertension and congestive heart failure due to the binding of these compounds to human neuropeptide y1
11/16/1999	US5985864 Polymorphs of donepezil hydrochloride and process for production
11/16/1999	CA2137811C Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/11/1999	WO1999057135A1 Antipicornaviral compounds, their preparation and use
11/11/1999	WO1999057098A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
11/11/1999	WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
11/11/1999	WO1999056750A1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
11/11/1999	WO1999042457A3 Substituted alxoxycarbonyl compounds
11/11/1999	WO1999040083A3 Bifunctional tryptase inhibitors
11/11/1999	WO1999040073A3 Tryptase inhibitors
11/11/1999	WO1998004528A3 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
11/11/1999	CA2330568A1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
11/11/1999	CA2329704A1 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
11/11/1999	CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
11/11/1999	CA2326763A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and methods for their synthesis
11/10/1999	CN1234797A N-substituted azaheterocyclic compound
11/10/1999	CN1234392A Optically active beta-alkamine compound and use thereof
11/10/1999	CN1046269C HIV protease inhibitors
11/09/1999	US5981754 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity
11/09/1999	US5981548 N-Hydroxypiperidines as superoxide radicals scavengers
11/09/1999	US5981539 Piperidine compounds as calcium channel blockers
11/09/1999	US5981531 For inhibiting platelet aggregation
11/09/1999	US5981073 Compounds based on dibenzoylresorcinol, and related compositions and articles
11/09/1999	US5980783 Synergistic stabilizer mixture
11/09/1999	CA2167912C Process for the preparation of sufentanil derivatives by carbene addition/aminolysis of 4-piperidone
11/09/1999	CA2133765C Cyclic-substituted unsymmetrical cyanine dyes
11/04/1999	WO1999055688A1 Substituted diarylalkyl amides as calcium channel antagonists
11/04/1999	WO1999055681A1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
11/04/1999	WO1999055676A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
11/04/1999	WO1999055674A1 1-[(1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
11/04/1999	WO1999055673A1 Arylphenyl-substituted cyclic keto enols
11/04/1999	WO1999055668A1 3-arylphenyl sulfide derivatives and insecticides and miticides
11/04/1999	WO1999055661A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors
11/04/1999	WO1999031074A3 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
11/04/1999	CA2330475A1 1-¬(1-substituted-4-piperidinyl)methyl\|-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
11/04/1999	CA2330304A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases
11/02/1999	US5977369 Process to prepare dihydropyridine and derivatives thereof
11/02/1999	US5977357 Phenyl alkyl ketone substituted by cyclic amine and a process for the preparation thereof
11/02/1999	US5977144 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
11/02/1999	US5977143 Medicament against infertility which reduces phagocytosis of spermatozoa in women
11/02/1999	US5977141 Sulfonamide inhibitors of matrix metalloproteinases
11/02/1999	US5977138 Alzheimer's disease
11/02/1999	US5977115 Alpha 1a adrenergic receptor antagonists
11/02/1999	US5977114 Selective thrombin inhibitors
11/02/1999	US5977027 Pyrimidone isobutyric acid and herbicides containing the same
11/02/1999	CA2197811C Intermediates in process for the preparation of n-substituted trifluoromethylphenyltetrahy-dropydrines
10/1999
10/28/1999	WO1999054321A1 Substituted diamines and their use as cell adhesion inhibitors
10/28/1999	WO1999054320A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
10/28/1999	WO1999054284A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999	WO1999024460B1 Dipeptide nitriles
10/28/1999	DE19818732A1 New aryl substituted cyclic ketoenol compounds useful for control of insects and as herbicides
10/28/1999	CA2328720A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
10/28/1999	CA2328413A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/27/1999	EP0952154A2 N-acyl and N-aroyl aralkyl amides
10/27/1999	EP0951466A2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/27/1999	CN1233256A Dipeptide benzamidine as a kininogenase inhibitor
10/27/1999	CN1233249A Spiro(cyclopent [B] indole-piperidines) and N-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and MAO inhibitors
10/27/1999	CN1233240A Synthesis of cisapride
10/26/1999	USRE36359 Long chain carboxylic acid imide ester
10/26/1999	US5973188 Anticoagulant; prevention cell, protein binding
10/26/1999	US5973040 Tetramethylpiperidine-containing copolymers
10/26/1999	US5972962 Treatment of pruritus
10/26/1999	US5972939 Cyclopentene derivatives useful as antagonists of the motilin receptor
10/26/1999	CA1340798C Disubstituted pyridines
10/21/1999	WO1999052876A1 Azacycloalkane derivatives, preparation and therapeutic application
10/21/1999	WO1999052873A1 A process for the preparation of amlodipine benzenesulphonate
10/21/1999	WO1999052872A1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN αvβ3 ANTAGONISTS
10/21/1999	WO1999052871A1 Liquid crystalline compound having piperidine ring, liquid crystal composition and liquid crystal display element
10/21/1999	WO1999046254A3 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis
10/21/1999	WO1999046245A3 PROCESSES FOR THE PREPARATION OF (R)-α- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
10/21/1999	WO1999037623A3 Sulphonamide derivatives for treatment of cns disorders
10/21/1999	WO1999026927A3 Metabotropic glutamate receptor antagonists for treating central nervous system diseases
10/21/1999	DE19816479A1 Intermolecular preparation of enamines by catalytic reaction of alkynes with ammonia or primary or secondary amines
10/20/1999	EP0950053A1 Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
10/20/1999	EP0950052A1 Method for preparing a tetrahydropyridin derivative
10/20/1999	EP0950051A1 Micro-particulate form of a tetrahydropyridin derivative
10/20/1999	EP0950050A1 Method for the crystallisation of a tetrahydopyridin derivative and resulting crystalline forms
10/20/1999	EP0950049A1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
10/20/1999	EP0950048A1 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease
10/20/1999	CN1232462A Muscarinic antagonists
10/20/1999	CN1232453A Ether muscarinic antagonists
10/20/1999	CN1232451A Substd. cyclic amine metalloprotease inhibitors
10/20/1999	CN1232399A Inhibitors of cysteine protease

1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 380